Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.

Huang KA, Rijal P, Jiang H, Wang B, Schimanski L, Dong T, Liu YM, Chang P, Iqbal M, Wang MC, Chen Z, Song R, Huang CC, Yang JH, Qi J, Lin TY, Li A, Powell TJ, Jan JT, Ma C, Gao GF, Shi Y, Townsend AR.

Nat Microbiol. 2019 Feb;4(2):306-315. doi: 10.1038/s41564-018-0303-7. Epub 2018 Nov 26.

PMID:
30478290
2.

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.

Stadlbauer D, Amanat F, Strohmeier S, Nachbagauer R, Krammer F.

Emerg Microbes Infect. 2018 Jun 20;7(1):110. doi: 10.1038/s41426-018-0115-0.

3.

Structural Insight into a Human Neutralizing Antibody against Influenza Virus H7N9.

Chen C, Liu L, Xiao Y, Cui S, Wang J, Jin Q.

J Virol. 2018 Feb 12;92(5). pii: e01850-17. doi: 10.1128/JVI.01850-17. Print 2018 Mar 1.

4.

Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.

Schmeisser F, Vasudevan A, Verma S, Wang W, Alvarado E, Weiss C, Atukorale V, Meseda C, Weir JP.

PLoS One. 2015 Jan 28;10(1):e0117108. doi: 10.1371/journal.pone.0117108. eCollection 2015.

5.

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.

Henry Dunand CJ, Leon PE, Huang M, Choi A, Chromikova V, Ho IY, Tan GS, Cruz J, Hirsh A, Zheng NY, Mullarkey CE, Ennis FA, Terajima M, Treanor JJ, Topham DJ, Subbarao K, Palese P, Krammer F, Wilson PC.

Cell Host Microbe. 2016 Jun 8;19(6):800-13. doi: 10.1016/j.chom.2016.05.014.

6.

A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.

Benjamin E, Wang W, McAuliffe JM, Palmer-Hill FJ, Kallewaard NL, Chen Z, Suzich JA, Blair WS, Jin H, Zhu Q.

J Virol. 2014 Jun;88(12):6743-50. doi: 10.1128/JVI.03562-13. Epub 2014 Apr 2.

7.

Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.

Henry Dunand CJ, Leon PE, Kaur K, Tan GS, Zheng NY, Andrews S, Huang M, Qu X, Huang Y, Salgado-Ferrer M, Ho IY, Taylor W, Hai R, Wrammert J, Ahmed R, García-Sastre A, Palese P, Krammer F, Wilson PC.

J Clin Invest. 2015 Mar 2;125(3):1255-68. doi: 10.1172/JCI74374. Epub 2015 Feb 17.

8.

Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus.

Ito M, Yamayoshi S, Murakami K, Saito K, Motojima A, Nakaishi K, Kawaoka Y.

Viruses. 2019 Feb 11;11(2). pii: E149. doi: 10.3390/v11020149.

9.

Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses.

Wang J, Chen Z, Bao L, Zhang W, Xue Y, Pang X, Zhang X, Qin C, Jin Q.

J Virol. 2015 Sep;89(17):9115-8. doi: 10.1128/JVI.01295-15. Epub 2015 Jun 10.

10.

Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses.

Iba Y, Fujii Y, Ohshima N, Sumida T, Kubota-Koketsu R, Ikeda M, Wakiyama M, Shirouzu M, Okada J, Okuno Y, Kurosawa Y, Yokoyama S.

J Virol. 2014 Jul;88(13):7130-44. doi: 10.1128/JVI.00420-14. Epub 2014 Apr 9.

11.

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection.

Tan GS, Leon PE, Albrecht RA, Margine I, Hirsh A, Bahl J, Krammer F.

PLoS Pathog. 2016 Apr 15;12(4):e1005578. doi: 10.1371/journal.ppat.1005578. eCollection 2016 Apr.

12.
13.

Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.

Liu L, Nachbagauer R, Zhu L, Huang Y, Xie X, Jin S, Zhang A, Wan Y, Hirsh A, Tian D, Shi X, Dong Z, Yuan S, Hu Y, Krammer F, Zhang X, Xu J.

J Infect Dis. 2017 Feb 15;215(4):518-528. doi: 10.1093/infdis/jiw608.

14.

A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA.

Bangaru S, Zhang H, Gilchuk IM, Voss TG, Irving RP, Gilchuk P, Matta P, Zhu X, Lang S, Nieusma T, Richt JA, Albrecht RA, Vanderven HA, Bombardi R, Kent SJ, Ward AB, Wilson IA, Crowe JE Jr.

Nat Commun. 2018 Jul 10;9(1):2669. doi: 10.1038/s41467-018-04704-9.

15.

Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure.

Tharakaraman K, Subramanian V, Cain D, Sasisekharan V, Sasisekharan R.

Cell Host Microbe. 2014 May 14;15(5):644-51. doi: 10.1016/j.chom.2014.04.009.

16.

H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.

Thornburg NJ, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley RM, Bombardi RG, Yu Y, Graham S, Branchizio A, Yoder SM, Rock MT, Creech CB, Edwards KM, Lee D, Li S, Wilson IA, García-Sastre A, Albrecht RA, Crowe JE Jr.

J Clin Invest. 2016 Apr 1;126(4):1482-94. doi: 10.1172/JCI85317. Epub 2016 Mar 7.

17.

Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.

Kwon HI, Kim YI, Park SJ, Song MS, Kim EH, Kim SM, Si YJ, Lee IW, Song BM, Lee YJ, Yun SJ, Kim WJ, Choi YK.

J Virol. 2017 May 12;91(11). pii: e02259-16. doi: 10.1128/JVI.02259-16. Print 2017 Jun 1.

18.

Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.

Dietrich MH, Ogden KM, Katen SP, Reiss K, Sutherland DM, Carnahan RH, Goff M, Cooper T, Dermody TS, Stehle T.

J Virol. 2017 Jan 31;91(4). pii: e01621-16. doi: 10.1128/JVI.01621-16. Print 2017 Feb 15.

19.

Divergent H7 immunogens offer protection from H7N9 virus challenge.

Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, García-Sastre A, Palese P.

J Virol. 2014 Apr;88(8):3976-85. doi: 10.1128/JVI.03095-13. Epub 2014 Jan 22.

20.

Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies.

Alvarado-Facundo E, Vassell R, Schmeisser F, Weir JP, Weiss CD, Wang W.

PLoS One. 2016 Feb 10;11(2):e0149149. doi: 10.1371/journal.pone.0149149. eCollection 2016.

Supplemental Content

Support Center